European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis2008; 25:457–507.
2.
SmallDLMorleyPBuchanAM. Current and experimental treatment of stroke; in DavisKLCharneyDCoyleJTNemeroffC (eds): Neuropsychopharmacology: The Fifth Generation of Progress. USA: American College of Neuropsychopharmacology, 2002: 1327–38.
3.
CaligiuriGKhallou-LaschetJVandaeleM. Phosphorylcholine-targeting immunization reduces atherosclerosis. J Am Coll Cardiol2007; 50:540–6.
4.
DuringMTSymesCWLawlorPA. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science2000; 25:1453–60.
5.
Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators.Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial. Stroke2005; 36:880–90.
6.
BangDKentSB. His6 tag-assisted chemical protein synthesis. Proc Natl Acad Sci USA2005; 102:5014–9.
7.
DawsonPEKentSB. Synthesis of native proteins by chemical ligation. Annu Rev Biochem2000; 69:923–60.
8.
BlankMBarzilaiOShoenfeldY. Molecular mimicry and autoimmunity. Clin Rev Allergy Immunol2007; 32:111–8.